Decoding the potential combinatorial effect of Nardostachys jatamansi, Withania somnifera, Bacopa monnieri , and Rauvolfia serpentina against schizophrenia: A multi-target systems pharmacology and molecular docking investigation

Schizophrenia is a heterogeneous neuropsychiatric illness with disrupted dopaminergic, serotonergic and glutamatergic neurotransmission, neuroinflammation and synaptic dysfunction for which, single-target antipsychotics have limited effectiveness. Nardostachys jatamansi, Withania somnifera, Bacopa monnieri and Rauvolfia serpentina are well-described in Ayurveda for psychosis, cognitive decline and mood disturbance, symptoms directly overlapping with the Schizophrenia spectrum. However, the mechanistic basis of their combinatorial effect across Schizophrenia-associated molecular targets remains undiscovered. The study systematically identified the multi-target, multi-component pharmacological mechanisms of a four-herb combination against Schizophrenia with an integrated network pharmacology and computational perspective and elucidated the relevant mechanistic basis for their rational application as polyherbal strategy. Using ADMET criteria, bioactive compounds of four medicinal plants were screened, and herb-disease targets were mapped using Venn diagram analysis. PPI network construction revealed 21 hub genes which were verified with SZDB 2.0. GO and pathway enrichment analyses; molecular docking of nine top priority targets; toxicity profiling; scaffold comparison with FDA-approved antipsychotics. The herb-target network showed extensive coverage of dopaminergic, serotonergic and glutamatergic pathways with 21 hub genes identified, nine of which were prioritized for docking. GO and pathway enrichment showed that neurotransmitter modulation was a prominent process. Docking confirmed potential favorable binding interactions, and scaffold analysis displayed that these compounds obtained structural similarities to FDA-approved antipsychotics. This study offers computational systems-level, mechanism-based evidence for the potential combinatorial effects of four-herb combination toward multiple schizophrenia-associated pathways. These results provide a rationale for the experimental validation and optimization of multi-component herbal interventions in schizophrenia.

Authors

Institutions

Publication Details

Journal
Journal of King Saud University - Science
Published
2026-11-17
DOI
https://doi.org/10.25259/jksus_706_2026
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Decoding the potential combinatorial effect of Nardostachys jatamansi, Withania somnifera, Bacopa monnieri , and Rauvolfia serpentina against schizophrenia: A multi-target systems pharmacology and molecular docking investigation

Anand Gaurav, Anjali Tripathi, Najwan Jubair
Journal of King Saud University - Science
Computational Drug Discovery Methods
article

Decoding the potential combinatorial effect of Nardostachys jatamansi, Withania somnifera, Bacopa monnieri , and Rauvolfia serpentina against schizophrenia: A multi-target systems pharmacology and molecular docking investigation

Anand Gaurav, Anjali Tripathi, Najwan Jubair
article en

Abstract

Schizophrenia is a heterogeneous neuropsychiatric illness with disrupted dopaminergic, serotonergic and glutamatergic neurotransmission, neuroinflammation and synaptic dysfunction for which, single-target antipsychotics have limited effectiveness. Nardostachys jatamansi, Withania somnifera, Bacopa monnieri and Rauvolfia serpentina are well-described in Ayurveda for psychosis, cognitive decline and mood disturbance, symptoms directly overlapping with the Schizophrenia spectrum. However, the mechanistic basis of their combinatorial effect across Schizophrenia-associated molecular targets remains undiscovered. The study systematically identified the multi-target, multi-component pharmacological mechanisms of a four-herb combination against Schizophrenia with an integrated network pharmacology and computational perspective and elucidated the relevant mechanistic basis for their rational application as polyherbal strategy. Using ADMET criteria, bioactive compounds of four medicinal plants were screened, and herb-disease targets were mapped using Venn diagram analysis. PPI network construction revealed 21 hub genes which were verified with SZDB 2.0. GO and pathway enrichment analyses; molecular docking of nine top priority targets; toxicity profiling; scaffold comparison with FDA-approved antipsychotics. The herb-target network showed extensive coverage of dopaminergic, serotonergic and glutamatergic pathways with 21 hub genes identified, nine of which were prioritized for docking. GO and pathway enrichment showed that neurotransmitter modulation was a prominent process. Docking confirmed potential favorable binding interactions, and scaffold analysis displayed that these compounds obtained structural similarities to FDA-approved antipsychotics. This study offers computational systems-level, mechanism-based evidence for the potential combinatorial effects of four-herb combination toward multiple schizophrenia-associated pathways. These results provide a rationale for the experimental validation and optimization of multi-component herbal interventions in schizophrenia.

Journal of King Saud University - ScienceVol. 0
University of Baghdad (IQ), Alsalam University College (IQ), University of Petroleum and Energy Studies (IN)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon